Murchinson’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Murchinson’s Portfolio SRTAW Stock Details SRTAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-61,209	Closed	-$168K	–	110
2021 Q2	$168K	Buy	+61,209	New	+$133K	0.06%	96

Other funds holding SRTAW

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

ICM

Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

BGIM

Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Murchinson's SRTAW Position: Q3 2021 in Review

Murchinson sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q3 2021, closing a stake of 61,209 shares — an estimated $168K sold.

Murchinson first reported a position in SRTAW in Q2 2021 and held it in 1 quarter. The position peaked at $168K in Q2 2021. 10 funds tracked by Wall St. Rank hold SRTAW as of Q3 2021.

Murchinson reported no remaining Strata Critical Medical Inc Warrants position as of Q3 2021 after selling out during the quarter.
Murchinson sold 61,209 Strata Critical Medical Inc Warrants shares in Q3 2021, an estimated $168K.
Murchinson first reported a position in Strata Critical Medical Inc Warrants in Q2 2021 and held it in 1 quarter.
Murchinson's Strata Critical Medical Inc Warrants position peaked at $168K in Q2 2021.
10 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q3 2021.

Based on Murchinson's 13F filing for Q3 2021, filed 15 Nov 2021.